Ambroxol Reneval, 7.5 mg/ml 4 ml 15 pcs

Studies have shown that the active ingredient of the drug, ambroxol, increases secretion in the respiratory tract. It increases production of pulmonary surfactant and stimulates ciliary activity. These effects result in increased mucus flow and transport (mucociliary clearance). Strengthening of mucociliary clearance improves sputum discharge and facilitates coughing.

In patients with chronic obstructive pulmonary disease long-term therapy with this drug (for at least 2 months) led to a significant reduction in exacerbations. There was a significant decrease in the duration of exacerbations and the number of days of antibiotic therapy.

Indications

Active ingredient

Composition

Interaction

Directions for use

Contraindications

Side effects

Ambroxol should not be taken simultaneously with anti-cough drugs that make it difficult to expectorate sputum.
The solution contains the preservative benzalkonium chloride, which when inhaled may cause bronchial spasm in sensitive patients with an overreactive airway.

Overdose

Similarities